BackOpthea Limited Overview

Opthea Limited Total Revenue

Latest total revenue for OPT: $150K, below the Healthcare sector average of $110B.

Get informed when a big investor buys or sells

+ Follow

Quarterly Revenue

$1093.00
98.29% YoY

As of Jun 2025

Annual Revenue (TTM)

$150108.00
2.24% YoY

Trailing 12 months ending Jun 2025

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading

Opthea Limited (OPT) FAQ

Opthea Limited (OPT) currently reports a total revenue of $150K as of June 2025. That compares with $150K in the prior-year period — down 2.2% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Opthea Limited's total revenue history and peer comparisons.

Opthea Limited's total revenue decreased from $150K to $150K — a 2.2% year-over-year decrease (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Opthea Limited's total revenue of $150K is lower than the Healthcare sector average of $110B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Opthea Limited reported $150K in total revenue as of June 2025. That compares with $150K in the prior-year period — down 2.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $150K, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Opthea Limited, and consider following OPT for alerts when major investors trade the stock.